The role of immunotherapy is well known in human epidermal growth factor 2 (HER2)-positive breast cancer patients, but its role in hormone receptor (HR)-positive and HER2-negative BC remains unexplored [5]. The gene discussed is NR4A1; the disease is breast carcinoma.